These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32912811)

  • 1. Critical aspects on traditional antivenom production processes and their optimization by factorial analysis.
    Zurbano BN; Tavarone E; Viacava BG; Dokmetjian JC; Cascone O; Fingermann M
    Biologicals; 2020 Nov; 68():65-73. PubMed ID: 32912811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.
    Al-Abdulla I; Casewell NR; Landon J
    J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pepsin digestion on the antivenom activity of equine immunoglobulins.
    Morais V; Massaldi H
    Toxicon; 2005 Dec; 46(8):876-82. PubMed ID: 16260020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the use of caprylic acid and ammonium sulfate in combination for the fractionation of equine antivenom F(ab')(2).
    Simsiriwong P; Eursakun S; Ratanabanangkoon K
    Biologicals; 2012 Sep; 40(5):338-44. PubMed ID: 22704919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionation of equine antivenom using caprylic acid precipitation in combination with cationic ion-exchange chromatography.
    Raweerith R; Ratanabanangkoon K
    J Immunol Methods; 2003 Nov; 282(1-2):63-72. PubMed ID: 14604541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration.
    León G; Segura A; Herrera M; Otero R; França FO; Barbaro KC; Cardoso JL; Wen FH; de Medeiros CR; Prado JC; Malaque CM; Lomonte B; Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1115-9. PubMed ID: 18561967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F(ab')2] antivenoms, in Bothrops asper bites in Colombia.
    Otero-Patiño R; Segura A; Herrera M; Angulo Y; León G; Gutiérrez JM; Barona J; Estrada S; Pereañez A; Quintana JC; Vargas LJ; Gómez JP; Díaz A; Suárez AM; Fernández J; Ramírez P; Fabra P; Perea M; Fernández D; Arroyo Y; Betancur D; Pupo L; Córdoba EA; Ramírez CE; Arrieta AB; Rivero A; Mosquera DC; Conrado NL; Ortiz R
    Toxicon; 2012 Feb; 59(2):344-55. PubMed ID: 22146491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
    León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
    Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of anti-horse antibodies induced by IgG, F(ab')2 and Fab applied repeatedly to rabbits. Effect on antivenom pharmacokinetics.
    Vázquez H; Olvera F; Alagón A; Sevcik C
    Toxicon; 2013 Dec; 76():362-9. PubMed ID: 24047962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative comparison on the refinement of horse antivenom by salt fractionation and ion-exchange chromatography.
    Saetang T; Treamwattana N; Suttijitpaisal P; Ratanabanangkoon K
    J Chromatogr B Biomed Sci Appl; 1997 Oct; 700(1-2):233-9. PubMed ID: 9390734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of 125I-labelled IgG, F(ab')2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use.
    Ismail M; Abd-Elsalam MA
    Toxicon; 1998 Nov; 36(11):1523-8. PubMed ID: 9792168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venoms, antivenoms and immunotherapy.
    Chippaux JP; Goyffon M
    Toxicon; 1998 Jun; 36(6):823-46. PubMed ID: 9663690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snake antivenoms from hyperimmunized horses: comparison of the antivenom activity and biological properties of their whole IgG and F(ab')2 fragments.
    Morais JF; de Freitas MC; Yamaguchi IK; dos Santos MC; da Silva WD
    Toxicon; 1994 Jun; 32(6):725-34. PubMed ID: 7940578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of preservatives on IgG aggregation, complement-activating effect and hypotensive activity of horse polyvalent antivenom used in snakebite envenomation.
    García M; Monge M; León G; Lizano S; Segura E; Solano G; Rojas G; Gutiérrez JM
    Biologicals; 2002 Jun; 30(2):143-51. PubMed ID: 12127316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions.
    León G; Monge M; Rojas E; Lomonte B; Gutiérrez JM
    Toxicon; 2001 Jun; 39(6):793-801. PubMed ID: 11137538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved purification and yield of the Egyptian snake Cerastes cerastes antitoxin by the use of caprylic acid.
    Seddik SS; Malak GA; Helmy MH
    J Nat Toxins; 2002 Dec; 11(4):323-8. PubMed ID: 12503875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans.
    Ameno S; Ameno K; Fuke C; Kiryu T; Ijiri I
    Toxicon; 1990; 28(3):347-50. PubMed ID: 2343468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.
    Gutiérrez JM; Rojas E; Quesada L; León G; Núñez J; Laing GD; Sasa M; Renjifo JM; Nasidi A; Warrell DA; Theakston RD; Rojas G
    Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):468-75. PubMed ID: 15837359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refinement strategy for antivenom preparation of high yield and quality.
    Kurtović T; Lang Balija M; Brgles M; Sviben D; Tunjić M; Cajner H; Marchetti-Deschmann M; Allmaier G; Halassy B
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007431. PubMed ID: 31206512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
    Gutiérrez JM; León G; Lomonte B
    Clin Pharmacokinet; 2003; 42(8):721-41. PubMed ID: 12846594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.